Search Results - Xuefang Liu

Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway by Lidan Jia, Xuefang Liu, Xinguang Liu, Qingzhou Guan, Yange Tian, Jiansheng Li, Peng Zhao

Connect to this object online.

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor by Peng Zhao, Peng Zhao, Peng Zhao, Xuefang Liu, Xuefang Liu, Xuefang Liu, Haoran Dong, Haoran Dong, Haoran Dong, Yange Tian, Yange Tian, Yange Tian, Suxiang Feng, Suxiang Feng, Di Zhao, Di Zhao, Di Zhao, Zhouxin Ren, Zhouxin Ren, Zhouxin Ren, Lanxi Zhang, Lanxi Zhang, Lanxi Zhang, Jiansheng Li, Jiansheng Li, Jiansheng Li

Connect to this object online.

Exposure to Air Pollution Exacerbates Inflammation in Rats with Preexisting COPD by Jing Wang, Ya Li, Peng Zhao, Yange Tian, Xuefang Liu, Huihui He, Rui Jia, Brian G. Oliver, Jiansheng Li

Connect to this object online.

Bufei Jianpi Formula Improves Mitochondrial Function and Suppresses Mitophagy in Skeletal Muscle via the Adenosine Monophosphate-Activated Protein Kinase Pathway in Chronic Obstruc... by Jing Mao, Jing Mao, Ya Li, Ya Li, Ya Li, Suxiang Feng, Suxiang Feng, Suxiang Feng, Xuefang Liu, Xuefang Liu, Yange Tian, Yange Tian, Qingqing Bian, Qingqing Bian, Qingqing Bian, Junzi Li, Junzi Li, Yuanyuan Hu, Yuanyuan Hu, Lanxi Zhang, Lanxi Zhang, Huige Ji, Huige Ji, Suyun Li, Suyun Li, Suyun Li

Connect to this object online.

Evaluation of Tolerability, Pharmacokinetics and Pharmacodynamics of Vicagrel, a Novel P2Y12 Antagonist, in Healthy Chinese Volunteers by Xiaojiao Li, Cai Liu, Xiaoxue Zhu, Haijing Wei, Hong Zhang, Hong Chen, Guiling Chen, Deming Yang, Hongbin Sun, Zhenwei Shen, Yifan Zhang, Wei Li, Jin Yang, Yongqiang Liu, Xiaojuan Lai, Yanchun Gong, Xuefang Liu, Yongguo Li, Dafang Zhong, Junqi Niu, Bin Liu, Yanhua Ding

Connect to this object online.